Tranzyme Acquires Canadian Drug Maker Neokimia | GenomeWeb

NEW YORK, Dec. 18 (GenomeWeb News) - Tranzyme has acquired Québec-based Neokimia, the companies said today.

 

Financial details were not disclosed. However, Vipin Garg, president and CEO of Tranzyme, said both companies were valued at around $7.5 million at the time of the deal. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.